Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
Maxime Breban, Julien Tap, Ariane Leboime...
https://pubmed.ncbi.nlm.nih.gov/28606969Actively Recruiting
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-15
400
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the differences in intestinal microbiota between patients with spondyloarthritis (SPA) or rheumatoid arthritis (RA) and healthy volunteers. The study aims to compare the biodiversity of gut bacteria by DNA sequencing to identify specific bacterial markers associated with each disease. Additionally, the study explores how clinical factors like age, gender, disease duration, and ongoing treatments relate to the gut microbiota composition and the connection between faecal and plasma metabolomes and intestinal bacteria. Participants include groups of 100 SPA patients, 100 RA patients, and 200 healthy control subjects. Biological samples of feces and blood are collected at the beginning of the study to analyze the microbiota. This observational research is conducted at the rheumatology department of Ambroise Paré hospital in France, focusing on gathering detailed data without administering treatments. Throughout the study, participants provide samples for bacterial and microbiota composition analysis, which are assessed up to four years after enrollment. Researchers monitor the gut bacteria profiles and their relation to clinical parameters over time. The study includes both patients and healthy adults, with evaluations centered on understanding microbiota differences and identifying potential biomarkers for SPA and RA.
CONDITIONS
Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At baseline
Participants provide faecal and blood samples to analyze the intestinal microbiota and related metabolome.
1 visit (in-person)
Duration - Up to 4 years
Participants are observed over time to study the composition of intestinal microbiota and its relation to clinical parameters.
Visits as needed for sample collection and assessments
Total: 1 location
1
Service de Rhumatologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris
Boulogne-Billancourt, France, 92100
Actively Recruiting
M
Maxime BREBAN, MD, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Maxime Breban, Julien Tap, Ariane Leboime...
https://pubmed.ncbi.nlm.nih.gov/28606969